Results 191 to 200 of about 4,227,028 (325)

Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab‐paclitaxel

open access: yesInternational Journal of Cancer, Volume 158, Issue 12, Page 3091-3100, 15 June 2026.
What's new? Adaptive immune responses are typically limited in pancreatic ductal adenocarcinoma, resulting in minimal efficacy of immune checkpoint inhibitors. Tumor Treating Fields (TTFields) therapy, which uses low‐intensity intermediate‐frequency electric fields to disrupt cancer cell processes, has been approved for certain cancers.
Tal Kan   +21 more
wiley   +1 more source

Phytochemicals from Astragalus zederbaueri as Acetylcholinesterase Inhibitors for Alzheimer's Therapy. [PDF]

open access: yesPLoS One
Asghar S   +7 more
europepmc   +1 more source

Estimation and rapid identification of later stages during embryonic development of the oviparous lizard Sceloporus aeneus (Squamata: Phrynosomatidae)

open access: yesThe Anatomical Record, Volume 309, Issue 6, Page 1583-1598, June 2026.
Abstract Stages of embryonic development for reptiles have been presented in tables that may include all or part of embryonic development. When oviposition occurs in some lizards, embryos are already in the later stages of development; likewise, the size of the eggs increases as incubation time progresses.
Nivia Rocio Antonio‐Rubio   +3 more
wiley   +1 more source

Micromorphological Characterization of Astragalus chamaephaca (Fabaceae) With Observations on Pollen Viability

open access: yesFeddes Repertorium, Volume 137, Issue 2, June 2026.
ABSTRACT Astragalus chamaephaca Freyn is a geographically restricted endemic species of Central Anatolia assigned to sect. Macrosemium Bunge. Detailed micromorphological data for this taxon have remained limited. This study provides a comprehensive account of pollen morphology, pollen viability, seed surface ornamentation, and indumentum characters ...
Fatma Taeb Dişli
wiley   +1 more source

Home - About - Disclaimer - Privacy